our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 10 August 2015

    Antares Pharma Reports Second Quarter 2015 Financial and Operating Results
  • 4 August 2015

    Antares Pharma Announces First Patients Enrolled in Quickshot Testosterone Supplemental Safety Study
  • 3 August 2015

    Antares Pharma to Host Second Quarter 2015 Operating and Financial Results Call
  • 14 July 2015

    Antares Pharma Appoints Peter J. Graham ESQ., Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer and Corporate Secretary
  • 16 June 2015

    Antares Pharma to Present at the JMP Securities Life Sciences Conference
  • 1 June 2015

    Antares Pharma Announces Additional Update to QuickShot Testosterone Program

latest products & technology

 

Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>